• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Supporting Ph+ ALL Patient: Emotional Challenges and Quality of Life

Opinion
Video

The panel highlights the quality of life and emotional challenges faced by patients diagnosed with Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL).

The following is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild, PharmD, MS, MBA, CPEL; Jonathon Abbas, MD; Vivian Tambe Tar, PharmD, MBA; Elias Jabbour, MD; and James McCloskey, MD.

The discussants focus on the impact of Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) and its treatment relating to patients' quality of life (QOL) and emotional well-being. Abbas noted the wide variation in patient age, from teenagers to octogenarians, each requiring personalized supportive care. The typically months-long treatment regimens with frequent clinic visits can be burdensome, especially for younger patients who may be building careers or families. Haumschild emphasized considering QOL goals, such as the ability to work and maintain mental health and relationships with loved ones. Monitoring QOL and adjusting care accordingly should be part of the treatment approach. The toxicity burden and its impact also require special attention in older patients with comorbidities. Overall, supporting patients with Ph+ ALL holistically emerges as a key priority.

Video synopsis is AI-generated and reviewed by AJMC editorial staff.

Related Videos
Dr Michael Morse, Duke University
Video 10 - "Bronchiectasis Exacerbation Management"
video 10  - "Developing Practical Solutions to Improve Cardiovascular Care"
video 10  - "Developing Practical Solutions to Improve Cardiovascular Care"
Video 6 - "Optimal Approaches to Diagnostic Testing for Type 1 Diabetes Mellitus"
Video 13 - "Concluding Thoughts on Ph+ ALL Treatment"
Video 12 - "The Future of Ph+ ALL Treatments"
dr lawrence eichenfield
dr krystyn van vliet
Raajit Rampal, MD, PhD, screenshot
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.